COVID-19 antidote VINCOV-19 ready for Phase-3 trials, market authorization Phasetwo clinical trials were conducted across multiple centers in India and
Continue readingCOVID-19 antidote VINCOV-19 ready for Phase-3 trials, market authorization Phasetwo clinical trials were conducted across multiple centers in India and
Continue reading